The real-world effectiveness of Monjuvi for relapsed or refractory diffuse large B-cell lymphoma in the U.S. was demonstrated ...

Annual Meeting & Exposition provides insights into the prognostic utility of geriatric assessment tools and their role in ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...

With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will ...

Fenske, MD led ECOG-ACRIN EA4151, the first randomized trial to compare treatment with or without stem cell transplant in patients with MRD-negative mantle cell lymphoma in first complete remission.

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announces new appointments of cancer researchers to lead committees in its expansive scientific program. ECOG-ACRIN is at the forefront of ...